The effectiveness of etilefrine in tilt-induced neurocardiogenic syncope wa
s assessed in a single-blind, randomized, placebo-controlled trial. Intrave
nous etilefrine was found to be safe and significantly more effective than
placebo in resolving the hemodynamic impairment induced by head-up tilt tes
ting in patients with neurocardiogenic syncope.